Value-based agreements come with risks and benefits, but a health system’s existing facilities and initiatives can help support the goals associated with them, JT Lew, PharmD, MBA, a managed care ...
Roche said its fenebrutinib drug candidate met primary goals in two late-stage trials for multiple sclerosis, reducing attacks or delaying disability progression in two different forms of the disease.
Each component of a SMART goal is designed to ensure that you have the proper framework to accomplish an objective. Instead of making open-ended wishes for the future, you make a purposeful plan. For ...
Contineum Therapeutics (CTNM) shares fell following the results from its mid-stage trial of PIPE-307, a treatment aimed at patients with relapsing-remitting multiple sclerosis. The trial did not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results